Atomoxetine Hydrochloride
"Atomoxetine Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A propylamine derivative and selective ADRENERGIC UPTAKE INHIBITOR that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
| Descriptor ID |
D000069445
|
| MeSH Number(s) |
D02.092.831.085
|
| Concept/Terms |
Atomoxetine Hydrochloride- Atomoxetine Hydrochloride
- Hydrochloride, Atomoxetine
- N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride
- Atomoxetine HCl
- HCl, Atomoxetine
|
Below are MeSH descriptors whose meaning is more general than "Atomoxetine Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Atomoxetine Hydrochloride".
This graph shows the total number of publications written about "Atomoxetine Hydrochloride" by people in this website by year, and whether "Atomoxetine Hydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 5 | 5 |
| 2017 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Atomoxetine Hydrochloride" by people in Profiles.
-
Acute vagus nerve stimulation enhances reversal learning in rats. Neurobiol Learn Mem. 2021 10; 184:107498.
-
Metabolic profiling of norepinephrine reuptake inhibitor atomoxetine. Eur J Pharm Sci. 2020 Oct 01; 153:105488.
-
Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD. Psychiatr Serv. 2017 Jul 01; 68(7):681-688.
-
Pharmacologic mood destabilization: case vignettes. CNS Spectr. 2009 Nov; 14(11 Suppl 11):9-11; discussion 12-4.
-
Atomoxetine for freezing of gait in Parkinson disease. J Neurol Sci. 2009 Sep 15; 284(1-2):177-8.
-
Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord. 2009 Jan 30; 24(2):277-82.
-
Atomoxetine attenuates dextroamphetamine effects in humans. Am J Drug Alcohol Abuse. 2009; 35(6):412-6.
-
Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. Depress Anxiety. 2009; 26(1):E23-5.
-
Pharmacotherapy with atomoxetine for US children and adolescents. Ann Clin Psychiatry. 2007 Jul-Sep; 19(3):175-80.
-
Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain. 2006 Aug; 129(Pt 8):2038-46.